Characteristics of Japanese Duchenne and Becker muscular dystrophy patients in a novel Japanese national registry of muscular dystrophy (Remudy)
- PMID: 23601510
- PMCID: PMC3639029
- DOI: 10.1186/1750-1172-8-60
Characteristics of Japanese Duchenne and Becker muscular dystrophy patients in a novel Japanese national registry of muscular dystrophy (Remudy)
Abstract
Background: Currently, clinical trials for new therapeutic strategies are being planned for Duchenne and Becker muscular dystrophies (DMD/BMD). However, it is difficult to obtain adequate numbers of patients in clinical trials. As solutions to these problems, patient registries are an important resource worldwide, especially in rare diseases such as DMD/BMD.
Methods: We developed a national registry of Japanese DMD/BMD patients in collaboration with TREAT-NMD. The registry includes male Japanese DMD/BMD patients whose genetic status has been confirmed by genetic analysis. The registry includes patients throughout Japan.
Results: As of February 2012, 583 DMD and 105 BMD patients were registered. Most individuals aged less than 20 years. In terms of genetic mutations of registrants of DMD and BMD, deletion of exons was the most frequent (61.4% and 79.0%) followed by point mutations (24.5% and 14.3%) and duplications (13.6% and 4.8%), respectively. 43.6% of DMD are capable of walking, and 76.2% of BMD registrants are able to walk. 41.1% of DMD registrants in the database were treated using steroids. 29.5% of DMD and 23.8% of BMD registrants were prescribed one cardiac medicine at least. 22% of DMD used ventilator support, and non-invasive support was common. Small numbers of DMD and BMD registrants, only 3.9% and 1.0% of them, have received scoliosis surgery. 57 (9.8%) patients were eligible to clinical trial focused on 'skipping' exon 51.
Conclusions: The Remudy has already demonstrated utility in clinical researches and standardization of patients care for DMD/BMD. This new DMD/BMD patient registry facilitates the synchronization of clinical drug development in Japan with that in other countries.
Figures



Similar articles
-
Exon skipping induced by nonsense/frameshift mutations in DMD gene results in Becker muscular dystrophy.Hum Genet. 2020 Feb;139(2):247-255. doi: 10.1007/s00439-019-02107-4. Epub 2020 Jan 9. Hum Genet. 2020. PMID: 31919629 Free PMC article.
-
A comprehensive database of Duchenne and Becker muscular dystrophy patients (0-18 years old) in East China.Orphanet J Rare Dis. 2015 Jan 23;10:5. doi: 10.1186/s13023-014-0220-7. Orphanet J Rare Dis. 2015. PMID: 25612904 Free PMC article.
-
Characteristics of Japanese Patients with Becker Muscular Dystrophy and Intermediate Muscular Dystrophy in a Japanese National Registry of Muscular Dystrophy (Remudy): Heterogeneity and Clinical Variation.J Neuromuscul Dis. 2018;5(2):193-203. doi: 10.3233/JND-170225. J Neuromuscul Dis. 2018. PMID: 29614690 Free PMC article.
-
[Infrastructure for new drug development to treat muscular dystrophy: current status of patient registration (remudy)].Brain Nerve. 2011 Nov;63(11):1279-84. Brain Nerve. 2011. PMID: 22068481 Review. Japanese.
-
Contributions of Japanese patients to development of antisense therapy for DMD.Brain Dev. 2016 Jan;38(1):4-9. doi: 10.1016/j.braindev.2015.05.014. Epub 2015 Jun 18. Brain Dev. 2016. PMID: 26094594 Review.
Cited by
-
Pharmacological Profile of Viltolarsen for the Treatment of Duchenne Muscular Dystrophy: A Japanese Experience.Clin Pharmacol. 2021 Dec 16;13:235-242. doi: 10.2147/CPAA.S288842. eCollection 2021. Clin Pharmacol. 2021. PMID: 34938127 Free PMC article. Review.
-
Exon skipping induced by nonsense/frameshift mutations in DMD gene results in Becker muscular dystrophy.Hum Genet. 2020 Feb;139(2):247-255. doi: 10.1007/s00439-019-02107-4. Epub 2020 Jan 9. Hum Genet. 2020. PMID: 31919629 Free PMC article.
-
Comparison of mutation profiles in the Duchenne muscular dystrophy gene among populations: implications for potential molecular therapies.Int J Mol Sci. 2015 Mar 9;16(3):5334-46. doi: 10.3390/ijms16035334. Int J Mol Sci. 2015. PMID: 25761239 Free PMC article.
-
New variants, challenges and pitfalls in DMD genotyping: implications in diagnosis, prognosis and therapy.J Hum Genet. 2014 Aug;59(8):454-64. doi: 10.1038/jhg.2014.54. Epub 2014 Jul 10. J Hum Genet. 2014. PMID: 25007885
-
Social difficulties and care burden of adult Duchenne muscular dystrophy in Japan: a questionnaire survey based on the Japanese Registry of Muscular Dystrophy (Remudy).Orphanet J Rare Dis. 2024 Apr 30;19(1):182. doi: 10.1186/s13023-024-03087-z. Orphanet J Rare Dis. 2024. PMID: 38689355 Free PMC article.
References
-
- Van Deutekom JC, Van Ommen GJ. Advances in Duchenne muscular dystrophy gene therapy. Nat Rev Genet. 2003;4:774–783. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials